Systematic Errors in the Evaluation of Side Effects
Abstract
Twenty-three inpatients at Hartford Hospital were selected for the pilot study of NIMH Collaborative Study III, testing the feasibility of high-dosage chlorpromazine in depressed patients. After random assignment to either a nonchecklist group or a checklist group, both groups were asked the following question: "Have you noticed any change in bodily function or had any physical complaints in the past week?" The nonchecklist group was asked no further questions, and only spontaneously reported symptoms were recorded. The checklist group was also asked specific questions from a list of possible drug side effects.
Statistical analysis in terms of both quantity and severity of side effects showed significantly greater numbers and greater severity of side effects reported in the checklist group. On the basis of these resuits the authors feel that unless reports of medication side effects are obtained in a uniform manner, the data collected under varying conditions of inquiry will not be comparable. Research findings based on such data could be invalid.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).